Application of quinone chalcone compound in the preparation of antitumor drugs
An anti-tumor drug, chalcone technology, applied in anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve problems such as death, tumor recurrence or metastasis in clinical patients, and inability to completely remove B16-OVA cells, and achieve tumor removal. Cells, no toxic side effects, high safety effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Example 1: Single use of the quinoidal chalcone compound of the present invention can effectively induce apoptosis of solid tumor and leukemia cells under 3D culture conditions.
[0068] 1. Experimental steps
[0069] Use 3D glue technology to culture A375, A549, HepG2, MCF-7, PANC-1 and HL-60 cells, the number of cells is about 10,000 per well, observe the state of the cells after 2 days, under good conditions, each cultured cells are separated according to The following groups were dosed:
[0070] Control group (control): common medium (such as RPMI-1640 medium) supplemented with glutamine;
[0071] Experimental group: 10 μmol / ml HB-2, HB-3, HB-7, HB-19, HB-25, HB-31, HB- 33. HB-46, DMF was used as positive control.
[0072]When adding the drug, the drug and the medium were evenly mixed and then added to each group of experimental cells. The start of adding the drug was recorded as day 0, and the cells in the 3D glue were detected for apoptosis at 96 hours (day 4)....
Embodiment 2
[0075] Example 2: Inhibitory growth of solid tumors and leukemias in vivo by small molecule inhibitor HB-2 and its structural analogues.
[0076] 1. Experimental steps
[0077] (1) Construction of A375 tumor-bearing mice: NON-SCID mice were subcutaneously inoculated with 1×10 5 A375 cells, when the tumor grows to 5mm x 5mm, the tumor-bearing mice were randomly divided into 10 groups, with 7 mice in each group, and the tumor-bearing mice were given the following different treatments:
[0078] Control group (control): intragastric administration of PBS;
[0079] Positive control group: intragastric administration of DMF (10 mg / kg), once every two days.
[0080] Experimental group (8 groups): Each group was given HB-2, HB-3, HB-7, HB-19, HB-25, HB-31, HB-33, HB-46 by intragastric administration, 10mg / kg body weight, Administer once every two days;
[0081] After the mice were sacrificed on the 21st day, the subcutaneous tumors were peeled off, and the tumor weights of each gr...
Embodiment 3
[0112] Example 3: The combination of IFN-β and HB-2 significantly induces the apoptosis of solid tumor cells and leukemia cells under 3D culture conditions.
[0113] 1. Experimental steps
[0114] Solid tumor cells A375, A549, HepG2, MCF-7, PANC-1, and leukemia cells HL-60 were cultured in 3D gel (24-well plate, cell density: 8000 / well), and the cell status and cell survival were observed the next day. In good condition, dosing treatment according to the following groups:
[0115] Control group 1 (control): common medium and drug solvent;
[0116] Control group 2 (IFNβ): add 6 ng / ml mouse or 10 ng / ml human IFNβ to normal culture medium;
[0117] Experimental group 3 (HB-2): adding 10 μmol / ml of HB-2 to normal culture medium;
[0118] Experimental group 4 (IFNβ+DMF): add 6ng / ml mouse or 10ng / ml human IFNβ and 20μmol / mlμM DMF to normal medium;
[0119] Experimental group 5 (IFNβ+HB-2): add 6 ng / ml mouse or 10 ng / ml human IFNβ and 10 μmol / ml HB-2 to normal medium;
[0120] W...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com